Showing 1 - 20 results of 58 for search 'Laurent Peyrin-Biroulet', query time: 0.05s
Refine Results
-
1
-
2
Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic by Ferdinando D’Amico, Laurent Peyrin-Biroulet, Silvio Danese
Published 2020-05-01
Article -
3
Can we change the natural course of inflammatory bowel disease? by Catherine Le Berre, Silvio Danese, Laurent Peyrin-Biroulet
Published 2023-04-01
Article -
4
Adaptive Designs: Lessons for Inflammatory Bowel Disease Trials by Ferdinando D'Amico, Silvio Danese, Laurent Peyrin-Biroulet
Published 2020-07-01
Article -
5
Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD) by Federica Furfaro, Elisa Ragaini, Laurent Peyrin-Biroulet, Silvio Danese
Published 2022-07-01
Article -
6
-
7
-
8
-
9
Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge by Pauline Wils, Bénédicte Caron, Ferdinando D’Amico, Silvio Danese, Laurent Peyrin-Biroulet
Published 2022-07-01
Article -
10
-
11
Early Intervention in Ulcerative Colitis: Ready for Prime Time? by Virginia Solitano, Ferdinando D’Amico, Eirini Zacharopoulou, Laurent Peyrin-Biroulet, Silvio Danese
Published 2020-08-01
Article -
12
-
13
Risk-Benefit of IBD Drugs: A Physicians and Patients Survey by Ferdinando D’Amico, Sophie Vieujean, Benedicte Caron, Laurent Peyrin-Biroulet, Silvio Danese
Published 2023-04-01
Article -
14
-
15
Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Condition... by Tommaso Lorenzo Parigi, Sophie Vieujean, Kristine Paridaens, Kira Dalgaard, Laurent Peyrin-Biroulet, Silvio Danese
Published 2023-11-01
Article -
16
-
17
Inflammatory Bowel Disease Patients’ Acceptance for Switching from Intravenous Infliximab or Vedolizumab to Subcutaneous Formulation: The Nancy Experience by Clotilde Remy, Bénédicte Caron, Celia Gouynou, Vincent Haghnejad, Elodie Jeanbert, Patrick Netter, Silvio Danese, Laurent Peyrin-Biroulet
Published 2022-12-01
Article -
18
-
19
Comparative Safety of Ustekinumab and Vedolizumab in Older Patients with Inflammatory Bowel Disease: A Bicentric Cohort Study by Alice Burgevin, Bénédicte Caron, Alexa Sasson, Amandine Luc, Patrick Netter, Cédric Baumann, Ashwin N. Ananthakrishnan, Laurent Peyrin-Biroulet
Published 2022-11-01
Article -
20